TISSIUM
Develops a nerve-healing polymer intended for surgical use, with a focus on bringing the technology into U.S. operating rooms.
Overview
TISSIUM is a Paris-based deep tech company developing a nerve-healing polymer that originated from PhD research. The company is positioning the material for use in operating rooms, with the latest round highlighting a push toward the U.S. surgical market. Its differentiation is the polymer-based approach to nerve healing, a specialized medical materials platform rather than an AI product. TISSIUM raised €60M in a June 2026 Series D, representing its disclosed funding to date and supporting efforts to take the technology into U.S. operating-room use.
Funding History
A PhD student’s nerve-healing polymer just raised €60M to take on the US operating room
Frequently Asked Questions
- How much funding does AI Funding track for TISSIUM?
- AI Funding tracks €60M for TISSIUM across 1 funding round in this database.
- Who are TISSIUM's investors?
- TISSIUM's investors include European Investment Bank.
- What does TISSIUM do?
- TISSIUM is a Paris-based deep tech company developing a nerve-healing polymer that originated from PhD research. The company is positioning the material for use in operating rooms, with the latest round highlighting a push toward the U.S. surgical market. Its differentiation is the polymer-based approach to nerve healing, a specialized medical materials platform rather than an AI product. TISSIUM raised €60M in a June 2026 Series D, representing its disclosed funding to date and supporting efforts to take the technology into U.S. operating-room use.
- Where is TISSIUM headquartered?
- TISSIUM is headquartered in Paris, France.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.